Wake up after midnight? Don’t worry—you’re in good company. From Odysseus to 14th-century monks, people once embraced a quiet or even productive interlude before returning to their ‘second sleep.’ So enjoy the pause and maybe even dream of Penelope!

www.linkedin.com/posts/greg-l...?

From citrus tests aboard 18th-century ships to today’s randomized controlled trials, the RCT transformed healing from ritual into science—revealing that even “nothing” could be powerful when measured with rigor. www.linkedin.com/pulse/rise-r...?

Digital twins are now being explored as tools to improve surgical planning, reduce errors, and even assist robotic procedures in real time. These virtual replicas of physical systems that learn, simulate, and predict performance.
www.forbes.com/sites/gregli...

The U.S. once set the global pace in drug discovery. Now, as China accelerates and our own innovation engine slows under regulation, the question isn’t can we lead again—it’s whether we’ll have the courage to reinvent how we govern science itself.
www.linkedin.com/pulse/americ...?

New blood test capable of detecting more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials to date
www.forbes.com/sites/gregli...

Would America approve one of the world’s most common medicines today?
More at www.licholai.com
www.linkedin.com/pulse/would-...

Pfizer plants a big flag in the obesity market and makes huge bet on Metsera
www.forbes.com/sites/gregli...

For the first time researchers have used generative AI to predict individual health risks. This is a scientific milestone for the future of medicine, prevention, and policy.
www.forbes.com/sites/gregli...

American leadership in developing innovative medicines is getting bogged down but REGULATORY PRAGMATISM can have quick impact.

www.forbes.com/sites/gregli...